Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer’s mice
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer’s mice
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-06-19
DOI
10.1038/srep11322
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The evolution of amidine-based brain penetrant BACE1 inhibitors
- (2014) Daniel Oehlrich et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease
- (2014) Arun K. Ghosh et al. CHEMICAL SOCIETY REVIEWS
- Targeting the β secretase BACE1 for Alzheimer's disease therapy
- (2014) Riqiang Yan et al. LANCET NEUROLOGY
- Cell-Penetrating Peptide-Mediated Therapeutic Molecule Delivery into the Central Nervous System
- (2013) Li-Li Zou et al. Current Neuropharmacology
- Inhibition of α-helix-mediated protein–protein interactions using designed molecules
- (2013) Valeria Azzarito et al. Nature Chemistry
- Alzheimer disease therapy—moving from amyloid-β to tau
- (2013) Ezio Giacobini et al. Nature Reviews Neurology
- Semagacestat for Treatment of Alzheimer's Disease
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Truncated and Helix-Constrained Peptides with High Affinity and Specificity for the cFos Coiled-Coil of AP-1
- (2013) Tara Rao et al. PLoS One
- Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
- (2012) Vladimir Coric et al. ARCHIVES OF NEUROLOGY
- Small-molecule BACE1 inhibitors: a patent literature review (2006 – 2011)
- (2012) Gary Probst et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Peptide Derived from HIV-1 TAT Protein Destabilizes a Monolayer of Endothelial Cells in anin VitroModel of the Blood-Brain Barrier and Allows Permeation of High Molecular Weight Proteins
- (2012) Itzik Cooper et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent
- (2012) Vivek Modi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation
- (2012) Demian Obregon et al. Nature Communications
- What the halted phase III γ-secretase inhibitor trial may (or may not) be telling us
- (2011) Nina F. Schor ANNALS OF NEUROLOGY
- CD45 Deficiency Drives Amyloid- Peptide Oligomers and Neuronal Loss in Alzheimer's Disease Mice
- (2011) Y. Zhu et al. JOURNAL OF NEUROSCIENCE
- Discovery of Cyclic Acylguanidines as Highly Potent and Selective β-Site Amyloid Cleaving Enzyme (BACE) Inhibitors: Part I—Inhibitor Design and Validation∥(1)
- (2010) Zhaoning Zhu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled Trial
- (2009) Robert C. Green JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now